The single-dose pharmacokinetics of liraglutide have been evaluated in sufferers with varying degrees of renal impairment. Patients with delicate (believed creatinine clearance 50-80 mL/min) to serious (approximated creatinine clearance fewer than thirty mL/min) renal impairment and clients with end